Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-22-012518
Filing Date
2022-03-28
Accepted
2022-03-28 18:59:58
Documents
1
Period of Report
2021-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4210
  Complete submission text file 0000899243-22-012518.txt   5822
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Issuer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address MOLECULAR INSIGHT PHARMCEUTICALS, INC. 160 SECOND STREET CAMBRIDGE MA 02142
Business Address
LaFrance Norman D. (Reporting) CIK: 0001397768 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34375 | Film No.: 22776899